Mission Wealth Management, LP Vertex Pharmaceuticals Inc Transaction History
Mission Wealth Management, LP
- $4.24 Billion
- Q4 2024
A detailed history of Mission Wealth Management, LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mission Wealth Management, LP holds 6,052 shares of VRTX stock, worth $2.84 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
6,052
Previous 6,627
8.68%
Holding current value
$2.84 Million
Previous $3.08 Million
20.93%
% of portfolio
0.06%
Previous 0.08%
Shares
26 transactions
Others Institutions Holding VRTX
# of Institutions
1,718Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12.6 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.9 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.54 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.22 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...